Heart failure and COVID-19
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
Heart failure is a common disease state that can be encountered at different stages in the course of a COVID-19 patient presentation. New or existing heart failure in the setting of COVID-19 can present a set of unique challenges that can complicate presentation, management, and prognosis. A careful understanding of the hemodynamic and diagnostic implications is essential for appropriate triage and management of these patients. Abnormal cardiac biomarkers are common in COVID-19 and can stem from a variety of mechanisms that involve the viral entry itself through the ACE2 receptors, direct cardiac injury, increased thrombotic activity, stress cardiomyopathy, and among others. The cytokine storm observed in this pandemic can be a culprit in many of the observed mechanisms and presentations. A correct understanding of the two-way interaction between heart failure medications and the infection as well as the proposed COVID-19 medications and heart failure can result in optimal management. Guideline-directed medical therapy for heart failure should not be interrupted for theoretical concerns but rather based on tolerance and clinical presentation. Initiating specific cardiac or heart failure medications to prevent the infection or mitigate the disease is also not an evidence-based practice at this time. Heart failure patients on advanced therapies including those with heart transplantation will particularly benefit from involving the advanced heart failure team members in the overall management if they contract the virus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Gautret, P., Lagier, J.-C., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Vieira, V. E., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105949 · Cited by 5,288
RetractedCardiovascular Disease, Drug Therapy, and Mortality in Covid-19
Mehra, M. R., Desai, S. S., Kuy, S., Henry, T. D., & Patel, A. N. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007621 · Cited by 1,428
RetractedClinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,958
Lai, C.-C., Shih, T.-P., Ko, W.-C., Tang, H.-J., & Hsueh, P.-R. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105924 · Cited by 6,068
Fourth universal definition of myocardial infarction (2018)
Thygesen, K., Alpert, J. S., Jaffe, A. S., Chaitman, B. R., Bax, J. J., Morrow, D. A., White, H. D., ESC Scientific Document Group, Thygesen, K., Alpert, J. S., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy462 · Cited by 5,880
Grasselli, G., Zangrillo, A., Zanella, A., Antonelli, M., Cabrini, L., Castelli, A., Cereda, D., Coluccello, A., Foti, G., Fumagalli, R., et al. (2020) · JAMA · doi:10.1001/jama.2020.5394 · Cited by 5,469
Ruan, Q., Yang, K., Wang, W., Jiang, L., & Song, J. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05991-x · Cited by 4,898
Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China
Shi, S., Qin, M., Shen, B., Cai, Y., Liu, T., Yang, F., Gong, W., Liu, X., Liang, J., Zhao, Q., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.0950 · Cited by 4,349
Fourth Universal Definition of Myocardial Infarction (2018)
Thygesen, K., Alpert, J. S., Jaffe, A. S., Chaitman, B. R., Bax, J. J., Morrow, D. A., & White, H. D. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.08.1038 · Cited by 4,118
Docherty, A. B., Harrison, E. M., Green, C. A., Hardwick, H. E., Pius, R., Norman, L., Holden, K. A., Read, J. M., Dondelinger, F., Carson, G., et al. (2020) · BMJ · doi:10.1136/bmj.m1985 · Cited by 3,481
A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445
(2020) · PubMed · doi:10.3760/cma.j.issn.0254-6450.2020.02.003 · Cited by 3,323
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
Fang, L., Karakiulakis, G., & Roth, M. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30116-8 · Cited by 2,911
CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis), Helms, J., Tacquard, C., Severac, F., Leonard-Lorant, I., Ohana, M., Delabranche, X., Merdji, H., Clere-Jehl, R., Schenck, M., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06062-x · Cited by 2,792
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong-Poi, H., et al. (2005) · Nature · doi:10.1038/nature03712 · Cited by 2,453
Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State
Arentz, M., Yim, E., Klaff, L., Lokhandwala, S., Riedo, F. X., Chong, M., & Lee, M. (2020) · JAMA · doi:10.1001/jama.2020.4326 · Cited by 2,259
Driggin, E., Madhavan, M. V., Bikdeli, B., Chuich, T., Laracy, J., Biondi-Zoccai, G., Brown, T. S., Der Nigoghossian, C., Zidar, D. A., Haythe, J., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.03.031 · Cited by 2,017
Abraham, W. T., Adamson, P. B., Bourge, R. C., Aaron, M. F., Costanzo, M. R., Stevenson, L. W., Strickland, W., Neelagaru, S., Raval, N., Krueger, S., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60101-3 · Cited by 1,744
Klok, F. A., Kruip, M. J. H. A., van der Meer, N. J. M., Arbous, M. S., Gommers, D., Kant, K. M., Kaptein, F. H. J., van Paassen, J., Stals, M. A. M., Huisman, M. V., et al. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.041 · Cited by 1,601
Ferrario, C. M., Jessup, J., Chappell, M. C., Averill, D. B., Brosnihan, K. B., Tallant, E. A., Diz, D. I., & Gallagher, P. E. (2005) · Circulation · doi:10.1161/circulationaha.104.510461 · Cited by 1,565
Paranjpe, I., Fuster, V., Lala, A., Russak, A. J., Glicksberg, B. S., Levin, M. A., Charney, A. W., Narula, J., Fayad, Z. A., Bagiella, E., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.05.001 · Cited by 920
Tikellis, C., & Thomas, M. C. (2012) · International Journal of Peptides · doi:10.1155/2012/256294 · Cited by 624
RICE, G. I., THOMAS, D. A., GRANT, P. J., TURNER, A. J., & HOOPER, N. M. (2004) · Biochemical Journal · doi:10.1042/bj20040634 · Cited by 619
Merx, M. W., & Weber, C. (2007) · Circulation · doi:10.1161/circulationaha.106.678359 · Cited by 603
Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase
Huang, Y., Tan, C., Wu, J., Chen, M., Wang, Z., Luo, L., Zhou, X., Liu, X., Huang, X., Yuan, S., et al. (2020) · Respiratory Research · doi:10.1186/s12931-020-01429-6 · Cited by 568
The Variety of Cardiovascular Presentations of COVID-19
Fried, J. A., Ramasubbu, K., Bhatt, R., Topkara, V. K., Clerkin, K. J., Horn, E., Rabbani, L., Brodie, D., Jain, S. S., Kirtane, A. J., et al. (2020) · Circulation · doi:10.1161/circulationaha.120.047164 · Cited by 548
Li, J., Wang, X., Chen, J., Zhang, H., & Deng, A. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.1624 · Cited by 541
COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs
TUFAN, A., AVANOĞLU GÜLER, A., & MATUCCI-CERINIC, M. (2020) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-2004-168 · Cited by 495
Clinical review: Myocardial depression in sepsis and septic shock.
Court, O., Kumar, A., Kumar, A., Parrillo, J. E., Kumar, A., & Kumar, A. (2002) · Critical Care · doi:10.1186/cc1822 · Cited by 406
COVID-19 in solid organ transplant recipients: A single-center case series from Spain
Fernández-Ruiz, M., Andrés, A., Loinaz, C., Delgado, J. F., López-Medrano, F., San Juan, R., González, E., Polanco, N., Folgueira, M. D., Lalueza, A., et al. (2020) · American Journal of Transplantation · doi:10.1111/ajt.15929 · Cited by 392
Tisdale, J. E., Jaynes, H. A., Kingery, J. R., Mourad, N. A., Trujillo, T. N., Overholser, B. R., & Kovacs, R. J. (2013) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.113.000152 · Cited by 385
Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19
Bozkurt, B., Kovacs, R., & Harrington, B. (2020) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2020.04.013 · Cited by 355
Prognostic value of NT-proBNP in patients with severe COVID-19
Gao, L., Jiang, D., Wen, X.-S., Cheng, X.-C., Sun, M., He, B., You, L.-N., Lei, P., Tan, X.-W., Qin, S., et al. (2020) · Respiratory Research · doi:10.1186/s12931-020-01352-w · Cited by 309
Myocardial and Systemic Inflammation in Acute Stress-Induced (Takotsubo) Cardiomyopathy
Scally, C., Abbas, H., Ahearn, T., Srinivasan, J., Mezincescu, A., Rudd, A., Spath, N., Yucel-Finn, A., Yuecel, R., Oldroyd, K., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.037975 · Cited by 297
Characteristics and Outcomes of Recipients of Heart Transplant With Coronavirus Disease 2019
Latif, F., Farr, M. A., Clerkin, K. J., Habal, M. V., Takeda, K., Naka, Y., Restaino, S., Sayer, G., & Uriel, N. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.2159 · Cited by 199
Ankersmit, H. J., Tugudea, S., Spanier, T., Weinberg, A. D., Artrip, J. H., Burke, E. M., Flannery, M., Mancini, D., Rose, E. A., Edwards, N. M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10359-8 · Cited by 194
Gorodeski, E. Z., Goyal, P., Cox, Z. L., Thibodeau, J. T., Reay, R. E., Rasmusson, K., Rogers, J. G., & Starling, R. C. (2020) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2020.04.008 · Cited by 189
Self-citationFirst cases of COVID-19 in heart transplantation from China
Li, F., Cai, J., & Dong, N. (2020) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2020.03.006 · Cited by 174
Global drug shortages due to COVID-19: Impact on patient care and mitigation strategies
Badreldin, H. A., & Atallah, B. (2021) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2020.05.017 · Cited by 174
Self-citationAlmazeedi, S., Al-Youha, S., Jamal, M. H., Al-Haddad, M., Al-Muhaini, A., Al-Ghimlas, F., & Al-Sabah, S. (2020) · eClinicalMedicine · doi:10.1016/j.eclinm.2020.100448 · Cited by 163
Association of Influenza-like Illness Activity With Hospitalizations for Heart Failure
Kytömaa, S., Hegde, S. M., Claggett, B. L., Udell, J. A., Rosamond, W. D., Temte, J. L., Nichol, K. L., Wright, J. D., Solomon, S. D., & Vardeny, O. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.0549 · Cited by 139
Atallah, B., Mallah, S. I., & Almahmeed, W. A. (2020) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvaa036 · Cited by 133
Self-citationDealing with surgical left ventricular assist device complications.
Kilic, A., Acker, M. A., & Atluri, P. (2015) · PubMed · doi:10.3978/j.issn.2072-1439.2015.10.64 · Cited by 129
Hayeshi, R. K., Masimirembwa, C. M., Mukanganyama, S., & Ungell, A.-L. B. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.05.009 · Cited by 128
Considerations for Heart Failure Care During the COVID-19 Pandemic
DeFilippis, E. M., Reza, N., DONALD, E. M., Givertz, M. M., Lindenfeld, J., & Jessup, M. L. (2020) · JACC Heart Failure · doi:10.1016/j.jchf.2020.05.006 · Cited by 124
Inflammation and Coagulation: Implications for the Septic Patient
Dellinger, R. P. (2003) · Clinical Infectious Diseases · doi:10.1086/374835 · Cited by 121
Andersson, C., Gerds, T. A., Fosbøl, E. L., Phelps, M. D., Andersen, J., Lamberts, M., Holt, A., Butt, J. H., Madelaire, C., Gislason, G., et al. (2020) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.007274 · Cited by 118
Javanian, M., Bayani, M., Shokri, M., Zavareh, M. S. H., Babazadeh, A., Yeganeh, B. S., Mohseni, S., Mehraeen, R., Sepidarkish, M., Bijani, A., et al. (2020) · Romanian Journal of Internal Medicine · doi:10.2478/rjim-2020-0013 · Cited by 115
Influence of hydroxychloroquine on the bioavailability of oral metoprolol
Somer, M., Kallio, J., Pesonen, U., Pyykkö, K. A., Huupponen, R., & Scheinin, M. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00197.x · Cited by 109
Clinical Features and Outcomes of 105 Hospitalized Patients With COVID-19 in Seattle, Washington
Buckner, F. S., McCulloch, D. J., Atluri, V., Blain, M., McGuffin, S. A., Nalla, A. K., Huang, M.-L., Greninger, A. L., Jerome, K. R., Cohen, S. A., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa632 · Cited by 109
QTc interval prolongation during favipiravir therapy in an Ebolavirus-infected patient
Chinello, P., Petrosillo, N., Pittalis, S., Biava, G., Ippolito, G., Nicastri, E., & on behalf of the INMI Ebola Team (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006034 · Cited by 93
Hamming, I., van Goor, H., Turner, A. J., Rushworth, C. A., Michaud, A., Corvol, P. L., & Navis, G. J. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2007.041855 · Cited by 87
Ren, Z., Hu, R., Wang, Z., Zhang, M., Ruan, Y., Wu, Z., Wu, H., Hu, X.-P., Hu, Z., Ren, W., et al. (2020) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2020.03.008 · Cited by 85
Chau, V. Q., Oliveros, E., Mahmood, K., Singhvi, A., Lala, A., Moss, N., Gidwani, U. K., MANCINI, D. M., Pinney, S., & Parikh, A. G. (2020) · JACC Case Reports · doi:10.1016/j.jaccas.2020.04.001 · Cited by 73
Clinical Characteristics of Coronavirus Disease 2019 (COVID-19): An Updated Systematic ReviewPreprint
Fang, Z., Fang, Y., Wu, K., Lai, K., Sun, X., 钟南山, & Liu, Z. (2020) · medRxiv · doi:10.1101/2020.03.07.20032573 · Cited by 61
The Inflammatory Response to Ventricular Assist Devices
Radley, G., Pieper, I. L., Alì, S., Bhatti, F., & Thornton, C. A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02651 · Cited by 52
Abnousi, F., Kang, G., Giacomini, J. C., Yeung, A. C., Zarafshar, S., Vesom, N., Ashley, E. A., Harrington, R. A., & Yong, C. M. (2019) · npj Digital Medicine · doi:10.1038/s41746-019-0159-0 · Cited by 24
Umapathi, P., Cuomo, K. K., Riley, S. J., Hubbard, A., MENZEL, K., SAUER, E., & Gilotra, N. A. (2020) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2020.06.003 · Cited by 10
Cited by
Wang, W., Wang, C.-Y., Wang, S.-I., & Wei, J. C.-C. (2022) · eClinicalMedicine · doi:10.1016/j.eclinm.2022.101619 · Cited by 335
Kendzerska, T., Zhu, D. T., Gershon, A. S., Edwards, J. D., Peixoto, C., Robillard, R., & Kendall, C. E. (2021) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s293471 · Cited by 279
Application of telemedicine in COVID-19: a bibliometric analysis
Lan, X., Yu, H., & Cui, L. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.908756 · Cited by 28
Pommier, T., Benzenine, E., Bernard, C., Mariet, A.-S., Béjot, Y., Giroud, M., Morgant, M.-C., Steinmetz, E., Guenancia, C., Bouchot, O., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10061231 · Cited by 15
“For example, many authors have underlined the influence of several factors during the first lockdown: the fear of putting additional pressure on hospitals and caregivers, the messages relayed by the media and health authorities to stay home to avoid the risk of COVID-19 contamination [14,17,18], the priority given to…”
Background
Metadata
- Authors
- Bader, F., Manla, Y., Atallah, B., & Starling, R. C.
- Venue
- Heart Failure Reviews
- Published
- 2020-07-27
- Volume
- 26
- Issue
- 1
- Pages
- 1-10
- ISSN
- 1382-4147 (ISSN-L)
- 1573-7322
- OpenAlex
- W3045608202
- Cited by
- 259
- References
- 66
- FWCI
- 5.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.